Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Zynerba Pharmaceuticals, Inc. (ZYNE)  
$1.30 0.00 (0.00%) as of 4:30 Tue 10/10


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 29,440,000
Market Cap: 38.27(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.3 - $1.39
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Zynerba Pharmaceuticals is engaged in pharmaceutically-produced transdermal cannabinoid therapies for neuropsychiatric disorders. Co. is focused on improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome (FXS), autism spectrum disorder (ASD), and 22q11.2 deletion syndrome (22q). Co. is developing Zygel, the pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol. Zygel is being developed as a clear gel with once- or twice-daily dosing and is targeting treatment of behavioral symptoms of FXS, ASD and 22q.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 48,835 173,289
Total Sell Value $0 $0 $64,066 $153,697
Total People Sold 0 0 11 12
Total Sell Transactions 0 0 11 26
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 139
  Page 6 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Fickenscher James E Chief Financial Officer   •       –      –    2016-12-07 4 B $14.03 $56,120 D/D 4,000 7,000 2.74     -
   Fickenscher James E Chief Financial Officer   •       –      –    2016-12-06 4 B $14.15 $42,450 D/D 3,000 3,000 2.74     -
   Hanlon Suzanne M. Sec, General Counsel & VP HR   •       –      –    2016-08-16 4 S $10.53 $31,590 I/I (3,000) 0     -
   Rapp Michael 10% Owner   –       –       •   2016-02-02 4 A $0.00 $0 D/D 80,467 1,344,115     -
   Baron Richard A Chief Financial Officer   •       –      –    2015-09-11 4 OE $3.98 $63,509 D/D 15,957 15,957     -
   Harrison Thomas L Director   –       •      –    2015-08-10 4 B $14.00 $175,000 D/D 12,500 12,500 2.39     -
   Anido Armando Chairman & Chief Exec. Officer   •       •      –    2015-08-10 4 A $0.00 $0 I/I 39,892 13,297     -
   Rapp Michael 10% Owner   –       –       •   2015-08-10 4 A $0.00 $0 D/D 567,505 1,263,648     -
   Hanlon Suzanne M. Sec, General Counsel & VP HR   •       –      –    2015-08-05 4 B $17.92 $53,760 I/I 3,000 3,000 1.99     -
   Anido Armando Chairman & Chief Exec. Officer   •       •      –    2015-08-04 3 IO $0.00 $0 D/D 0 332,512     -
   Sebree Terri B PresidentOfficer   •       –      –    2015-08-04 3 IO $0.00 $0 D/D 0 178,746     -
   Rapp Michael 10% Owner   –       –       •   2015-08-04 3 IO $0.00 $0 I/I 0 80,467     -
   Rapp Michael 10% Owner   –       –       •   2015-08-04 3 IO $0.00 $0 D/D 0 696,143     -
   Hanlon Suzanne M. General CounselOfficer   •       –      –    2015-08-04 3 IO $0.00 $0 D/D 0 39,893     -

  139 Records found
  1  2  3  4  5  6    
  Page 6 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed